Predictive oncology reports first quarter financial results

Eagan, minn., may 12, 2022 (globe newswire) -- the financial results from the first quarter we believe depicts a solid potential for growth in the upcoming period, in accordance with the report by predictive oncology inc. (nasdaq: poai) today, disclosing the results for the quarter ended march 31, 2022. the consolidated results of predictive oncology's reportable segments included recognized revenue of $314,568 for the quarter.
POAI Ratings Summary
POAI Quant Ranking